Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT07662044

Public ClinicalTrials.gov record NCT07662044. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus (Eluminate-1)

Study identification

NCT ID
NCT07662044
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
800 participants

Conditions and interventions

Interventions

  • Elecoglipron Drug
  • Dapagliflozin Drug
  • Elecoglipron-matched placebo Drug
  • Dapagliflozin-matched placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 5, 2026
Primary completion
Jul 13, 2028
Completion
Jul 13, 2028
Last update posted
Jul 14, 2026

2026 – 2028

United States locations

U.S. sites
27
U.S. states
17
U.S. cities
27
Facility City State ZIP Site status
Research Site Birmingham Alabama 35233 Not yet recruiting
Research Site Daphne Alabama 36526 Not yet recruiting
Research Site Lomita California 90717 Not yet recruiting
Research Site Los Alamitos California 90720 Not yet recruiting
Research Site San Diego California 92111 Suspended
Research Site Walnut Creek California 94598 Suspended
Research Site Englewood Colorado 80110 Not yet recruiting
Research Site Bridgeport Connecticut 06606 Not yet recruiting
Research Site Jacksonville Florida 32256 Not yet recruiting
Research Site Orlando Florida 32801 Not yet recruiting
Research Site Conyers Georgia 30094 Not yet recruiting
Research Site Decatur Georgia 30030 Not yet recruiting
Research Site Hinesville Georgia 31313 Not yet recruiting
Research Site El Dorado Kansas 67042 Not yet recruiting
Research Site Newton Kansas 67114 Not yet recruiting
Research Site Lexington Kentucky 40509 Not yet recruiting
Research Site Covington Louisiana 70433 Not yet recruiting
Research Site Bowie Maryland 20715 Not yet recruiting
Research Site Southfield Michigan 48075 Not yet recruiting
Research Site Kansas City Missouri 64111 Not yet recruiting
Research Site St Louis Missouri 63141 Not yet recruiting
Research Site Las Vegas Nevada 89119 Not yet recruiting
Research Site Anderson South Carolina 29621 Not yet recruiting
Research Site Knoxville Tennessee 37909 Not yet recruiting
Research Site Fort Worth Texas 76135 Suspended
Research Site Irving Texas 75061 Not yet recruiting
Research Site Renton Washington 98057 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 122 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07662044, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 14, 2026 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07662044 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →